Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18394103> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q18394103 subject Q7427150.
- Q18394103 subject Q8515266.
- Q18394103 subject Q8824860.
- Q18394103 abstract "Resminostat (4SC-201 or RAS2410) is an orally bioavailable inhibitor of histone deacetylases (HDACs), of which inhibitors are antineoplastic agents.In 2011, the German drug maker 4SC was granted orphan drug designation for resminostat by the Food and Drug Administration for the treatment of hepatocellular carcinoma (HCC).In 2016 the FDA granted [another?] IND for clinical tests in combination with sorafenib for HCC. 4SC say "In several phase I and phase II trials, resminostat has already demonstrated very good safety and tolerability, alongside promising indications of efficacy."".
- Q18394103 iupacName "(2E)-3-[1-({4-[(Dimethylamino)methyl]phenyl}sulfonyl)-1H-pyrrol-3-yl]-N-hydroxyacrylamide".
- Q18394103 thumbnail Resminostat.svg?width=300.
- Q18394103 wikiPageWikiLink Q1148337.
- Q18394103 wikiPageWikiLink Q1367466.
- Q18394103 wikiPageWikiLink Q14599311.
- Q18394103 wikiPageWikiLink Q14905392.
- Q18394103 wikiPageWikiLink Q174378.
- Q18394103 wikiPageWikiLink Q177900.
- Q18394103 wikiPageWikiLink Q17916086.
- Q18394103 wikiPageWikiLink Q18344027.
- Q18394103 wikiPageWikiLink Q188909.
- Q18394103 wikiPageWikiLink Q204711.
- Q18394103 wikiPageWikiLink Q242736.
- Q18394103 wikiPageWikiLink Q36293.
- Q18394103 wikiPageWikiLink Q421136.
- Q18394103 wikiPageWikiLink Q4701858.
- Q18394103 wikiPageWikiLink Q4875408.
- Q18394103 wikiPageWikiLink Q5113739.
- Q18394103 wikiPageWikiLink Q6060674.
- Q18394103 wikiPageWikiLink Q7117944.
- Q18394103 wikiPageWikiLink Q7427150.
- Q18394103 wikiPageWikiLink Q8515266.
- Q18394103 wikiPageWikiLink Q8824860.
- Q18394103 wikiPageWikiLink Q974135.
- Q18394103 iupacname "-3".
- Q18394103 name "Resminostat".
- Q18394103 type ChemicalCompound.
- Q18394103 type ChemicalSubstance.
- Q18394103 type ChemicalObject.
- Q18394103 type Thing.
- Q18394103 type Q11173.
- Q18394103 comment "Resminostat (4SC-201 or RAS2410) is an orally bioavailable inhibitor of histone deacetylases (HDACs), of which inhibitors are antineoplastic agents.In 2011, the German drug maker 4SC was granted orphan drug designation for resminostat by the Food and Drug Administration for the treatment of hepatocellular carcinoma (HCC).In 2016 the FDA granted [another?] IND for clinical tests in combination with sorafenib for HCC.".
- Q18394103 label "Resminostat".
- Q18394103 depiction Resminostat.svg.
- Q18394103 name "Resminostat".